Advanced Cancers

Oncology
9
Pipeline Programs
5
Companies
8
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
5
2
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 8 programs with unclassified modality

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Teva
TevaIsrael - Petach Tikva
1 program
1
Fentanyl Buccal TabletPhase 21 trial
Active Trials
NCT01856114Completed36Est. Dec 2019
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
IlorasertibPhase 2Small Molecule1 trial
Active Trials
NCT02478320Terminated12Est. May 2022
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
IONIS-STAT3RxPhase 1/21 trial
Active Trials
NCT01563302Completed64Est. Mar 2016
Ionis Pharmaceuticals
1 program
1
IONIS-STAT3RxPhase 1/2
CT
5 programs
5
TQB2252 injectionPhase 11 trial
TQB2922 injectionPhase 11 trial
TQB2930 injectionPhase 11 trial
TQB3107 TabletsPhase 11 trial
TQB3602 Capsule + AK105 InjectionPhase 11 trial
Active Trials
NCT06649656Not Yet RecruitingEst. Dec 2026
NCT07260708RecruitingEst. Dec 2028
NCT05380882UnknownEst. Dec 2023
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
AbbVieIlorasertib
TevaFentanyl Buccal Tablet
AstraZenecaIONIS-STAT3Rx
Chia Tai TianQing Pharmaceutical GroupTQB2922 injection
Chia Tai TianQing Pharmaceutical GroupTQB2252 injection
Chia Tai TianQing Pharmaceutical GroupTQB3107 Tablets
Chia Tai TianQing Pharmaceutical GroupTQB3602 Capsule + AK105 Injection
Chia Tai TianQing Pharmaceutical GroupTQB2930 injection

Clinical Trials (8)

Total enrollment: 112 patients across 8 trials

NCT02478320AbbVieIlorasertib

Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors

Start: Aug 2016Est. completion: May 202212 patients
Phase 2Terminated
NCT01856114TevaFentanyl Buccal Tablet

Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea

Start: May 2014Est. completion: Dec 201936 patients
Phase 2Completed
NCT01563302AstraZenecaIONIS-STAT3Rx

Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers

Start: Feb 2012Est. completion: Mar 201664 patients
Phase 1/2Completed
NCT07260708Chia Tai TianQing Pharmaceutical GroupTQB2922 injection

Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers

Start: Dec 2025Est. completion: Dec 2028
Phase 1Recruiting
NCT06649656Chia Tai TianQing Pharmaceutical GroupTQB2252 injection

A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors

Start: Nov 2024Est. completion: Dec 2026
Phase 1Not Yet Recruiting
NCT06413953Chia Tai TianQing Pharmaceutical GroupTQB3107 Tablets

A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors

Start: Jun 2024Est. completion: Dec 2026
Phase 1Recruiting
NCT05333276Chia Tai TianQing Pharmaceutical GroupTQB3602 Capsule + AK105 Injection

Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers

Start: Jul 2022Est. completion: May 2024
Phase 1Unknown
NCT05380882Chia Tai TianQing Pharmaceutical GroupTQB2930 injection

Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers

Start: May 2022Est. completion: Dec 2023
Phase 1Unknown

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1m ago

Office Administrator

SystImmune
1m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
12m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
15m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
15m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 112 patients
5 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)